Effects of eplerenone on glucose metabolism and blood pressure in hypertensive patients with obesity
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Eplerenone (Primary) ; Trichlormethiazide
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 20 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 17 Apr 2015 According to UMIN, the date for data entry closure is 2016/12/31, and the date for conclusion of data analysis is 2017/02/28.
- 17 Apr 2015 Planned End Date changed from 31 Dec 2015 to 30 Sep 2016 as reported by University Hospital Medical Information Network - Japan record.